Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 19, 2021 (5 years ago)

Oxycodone Hydrochloride Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Tablets/Capsules; A single foreign tablet Hydrochlorothiazide/Lisinopril 25/20 was found in one bottle

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Oxycodone Hydrochloride Tablets, USP, 10 mg, 100 count bottle, Rx only, Marketed by: Rhodes Pharmaceuticals L.P., Coventry RI 02816, Manufactured by: Purdue Pharma L.P., Stanford, CT 06901 NDC 42858-002-01

Affected NDC 42858-0002-01

Compare with the code on your package — it is the most precise check available.

Drug: Oxycodone

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Oxycodone Hydrochloride
NDC 42858-0002
10 mg/1 Tablet
Oral
Rhodes Pharmaceuticals LLC Rx · CII
Recalling firm
Rhodes Pharmaceuticals, L.P.
NDC code
42858-002-01
Origin
RI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0794-2021 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Oxycodone recalls

See all
Class II · Moderate risk

Oxycodone Hydrochloride Tablets

Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.

Ongoing Packaging defect Amerisource Health Services LLC NDC 68084-354-01 D-0338-2026

Other recalls by Rhodes Pharmaceuticals, L.P.

All 2021 recalls
Class III · Low risk

Aptensio XR

Failed Dissolution Specification: Low dissolution outside of specifications

Terminated Dissolution failure Rhodes Pharmaceuticals, L.P. NDC 42858-402-45 D-0710-2018